Abbott Laboratories (ABT)
(Delayed Data from NYSE)
$127.29 USD
+1.10 (0.87%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $127.29 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Abbott Laboratories has a market cap of $219.55B, which represents its share price of $126.19 multiplied by its outstanding shares number of 1.74B. As a large-cap company, ABT's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ABT 127.29 +1.10(0.87%)
Will ABT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ABT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ABT
HCA Beats Q2 Earnings on Higher Admissions, Ups '25 EPS View
Hologic's International Momentum Takes Shape: Will Execution Pay Off?
ABT: What are Zacks experts saying now?
Zacks Private Portfolio Services
The Zacks Analyst Blog Highlights Wells Fargo, Abbott Laboratories, American Express, TSS and Maui Land & Pineapple
Top Stock Reports for Wells Fargo, Abbott & American Express
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know
Other News for ABT
IXJ: A Bet On Global Healthcare Recovery
This New ETF Brings Out The Best In S&P 500 Without The Tech Overload
Thermo Fisher Scientific Inc Sees Significant Reduction in Eaton Vance Worldwide Health ...
BME: The Resilient Income Investment Of The Healthcare Industry
Best Dividend Aristocrats For August 2025